Shanghai Aohua Photoelectric Endoscope (688212.SH) executives plan to increase their holdings by RMB 3.7 million to RMB 6.2 million.

17:30 22/09/2024

Olympus (688212.SH) announcement, the company recently received the resignation of Shi Xiaojiang, vice president and secretary of the board of directors...

Announcement from Shanghai Aohua Photoelectricity Endoscope (688212.SH): The company recently received a notification letter from the vice general manager and board secretary Shi Xiaojiang, vice general manager Chen Peng, vice general manager Bao Hanjing, and vice general manager Wang Xiguang. Based on the confidence in the company's future stable development and the recognition of the long-term investment value of the company's stock, they plan to increase their holdings of the company's stock through the Shanghai Stock Exchange system-authorized methods (including but not limited to centralized bidding trading, block trading, etc.) starting from September 23, 2024, for a period of 6 months. The total amount of the increase shall not be less than RMB 3.7 million (inclusive) and not more than RMB 6.2 million (inclusive).

A new drug was rejected by the FDA upon entering the market, causing Biohaven (BHVN.US) stock price to plummet by 40%. Bank of America downgraded the rating to "Neutral".

HK Stock Market Move | DATANG POWER (00991) rose nearly 5%. Institutions believe that the company's significant impairment of assets may alleviate pressure on fourth-quarter operating performance.

HK Stock Market Move | WASION HOLDINGS (03393) rose by more than 7% with the rise of the AI industry driving electricity demand, and data center customers promoting the company's smart power distribution business.

A new drug was rejected by the FDA upon entering the market, causing Biohaven (BHVN.US) stock price to plummet by 40%. Bank of America downgraded the rating to "Neutral".

HK Stock Market Move | DATANG POWER (00991) rose nearly 5%. Institutions believe that the company's significant impairment of assets may alleviate pressure on fourth-quarter operating performance.